Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations

J Clin Oncol. 1983 Mar;1(3):190-7. doi: 10.1200/JCO.1983.1.3.190.

Abstract

A diagnosis of chronic lymphocytic leukemia (CLL) was made in 81 patients referred for peripheral blood lymphocyte typing (PBL). A retrospective review was undertaken to see if correlations existed between surface marker phenotype-determined subclasses and clinical features. Surface markers utilized were surface immunoglobulin (sIg), sheep erythrocyte receptor (E), 65,000-dalton human T lymphocyte antigen (T65), Ia antigen, and for sIg+ cells, heavy and light chains. All patients were Ia+. Cells of 70% of patients were sIg+ E- T65+ Ia+, and the clinical heterogeneity was that of classical CLL. Eight of the nine patients with sIg+ E- T65- Ia+ cells had a paraprotein. The sIg- E+ T65+ Ia+ phenotype represented classical T cell CLL. Three of the five patients in the sEg- E- T65+ Ia+ group had significant albuminuria, and two had nephrotic-range proteinuria. Use of additional monoclonal antibodies to B cell surface antigens should further subclassify CLL and other lymphoproliferative disorders. Interesting clinical correlations with certain phenotypic subclasses do exist, and further subclassification and long-term follow-up may yield correlations between phenotypes and prognosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigen-Antibody Complex / analysis
  • Antigens, Neoplasm / analysis*
  • Antigens, Surface / analysis*
  • Erythrocytes / immunology
  • Female
  • Follow-Up Studies
  • Histocompatibility Antigens Class II / analysis
  • Humans
  • Immunoglobulins / analysis
  • Leukemia, Hairy Cell / immunology
  • Leukemia, Hairy Cell / therapy
  • Leukemia, Lymphoid / immunology*
  • Leukemia, Lymphoid / therapy
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / therapy
  • Male
  • Phenotype
  • Prognosis
  • Retrospective Studies
  • T-Lymphocytes / immunology*

Substances

  • Antigen-Antibody Complex
  • Antigens, Neoplasm
  • Antigens, Surface
  • Histocompatibility Antigens Class II
  • Immunoglobulins